title: Influence of osteogenic stimulation and VEGF treatment on in vivo bone formation in hMSC-seeded cancellous bone scaffolds.
abstract: BACKGROUND
  Tissue engineering approaches for reconstruction of large bone defects are still technically immature, especially in regard to sufficient blood supply. Therefore, the aim of the present study was to investigate the influence of osteogenic stimulation and treatment with VEGF on new bone formation and neovascularization in hMSC-loaded cancellous bone scaffolds in vivo.
  
  
  METHODS
  Cubic scaffolds were seeded with hMSC and either cultured in stem cell medium or osteogenic stimulation medium. One osteogenically stimulated group was additionally treated with 0.8 μg VEGF prior to subcutaneous implantation in athymic mice. After 2 and 12 weeks in vivo, constructs and selected organs were harvested for histological and molecular analysis.
  
  
  RESULTS
  Histological analysis revealed similar vascularization of the constructs with and without VEGF treatment and absence of new bone formation in any group. Human DNA was detected in all inoculated scaffolds, but a significant decrease in cells was observed after 2 weeks with no further decrease after 12 weeks in vivo.
  
  
  CONCLUSIONS
  Under the chosen conditions, osteogenic stimulation and treatment with VEGF does not have any influence on the new bone formation and neovascularization in hMSC-seeded cancellous bone scaffolds.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Lenze
authors.forename: Florian
authors.initials: F
authors.lastname: Pohlig
authors.forename: Sebastian
authors.initials: S
authors.lastname: Seitz
authors.forename: Christina
authors.initials: C
authors.lastname: Ern
authors.forename: Stefan
authors.initials: S
authors.lastname: Milz
authors.affiliation: Laboratory of Experimental Surgery and Regenerative Medicine, Department of Surgery, University of Munich (LMU), Munich, Germany. denitsa.docheva@med.uni-muenchen.de.
authors.forename: Denitsa
authors.initials: D
authors.lastname: Docheva
authors.forename: Matthias
authors.initials: M
authors.lastname: Schieker
mesh_terms: D000818:Animals; D002452:Cell Count; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D008819:Mice, Nude; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology*; D023822:Tissue Engineering; D054457:Tissue Scaffolds; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology*
chemical_list: D042461:Vascular Endothelial Growth Factor A; D004247:DNA